29Jul
Financial Daily Dose 7.29.2019 | Top Story: Pfizer and Mylan Join Forces to Create Generics Powerhouse
Drug giants Pfizer and Mylan have inked a deal that will merge the former’s off-patent drugs with the latter’s generics business, a tie-up that creates a mammoth global seller of lower-priced medicines....
By:
Robins Kaplan LLP
Related
Our "2020 securities, shareholder, and M&A litigation outlook" provides our point of view on 2020, i...
Read More >
In a recent claim filed against one of our clients, an aggrieved employee alleged that a manager who...
Read More >
Since COVID-19, deals involving foreign state-owned enterprises or enterprises related to public hea...
Read More >
The Department of Defense (DOD) recently promulgated a final rule limiting the DOD’s ability to use...
Read More >
On Feb. 18, 2019, the New York City Commission on Human Rights released new legal enforcement guidan...
Read More >
Parents’ need to attend CSE/IEP meetings of a child with a serious health condition is now consider...
Read More >